Calamos Advisors LLC
Q4 2022 13F-HR Holdings
Net value change ($000)
-547,162
(-2.5%)
New positions
197
Sold out positions
305
Turnover %
24.7%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q3 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| VOO | 471,058 | NEW |
| NEE | 74,453 | NEW |
| DTE | 41,350 | NEW |
| FXI | 38,697 | NEW |
| ORCL | 28,878 | 105.3% |
| MA | 25,567 | 31.5% |
| TMUS | 23,858 | 252.6% |
| TEVOGEN BIO HLDGS INC COM | 20,660 | NEW |
| Rigel Resource Acquisition Corp. | 20,580 | NEW |
| AEP | 19,605 | 27.9% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
603,264
(2.8% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|